Skip to content

SulNOx Group PLC - Subscription for New Shares


Announcement provided by

SulNOx Group Plc · SNOX

22/12/2023 07:00

SulNOx Group PLC - Subscription for New Shares
RNS Number : 6911X
SulNOx Group PLC
22 December 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

 

 22 December 2023

 

SulNOx Group Plc (the "Company" or "SulNOx")

 

Subscription for New Shares

Holdings in the Company

Total Voting Rights

(Aquis Stock Exchange: SNOX)

 

Subscription for New Shares

 

The board of directors of the Company (the "Board") is pleased to announce that a group of investors, consisting of both new and existing shareholders (the "Investors"), have agreed to subscribe for a total of 7,826,088 new ordinary shares of 2 pence each ("Ordinary Shares") at a price of 23.0 pence per Ordinary Share (representing a discount of 11.5% to the average closing price of the Ordinary Shares for the last 5 trading days of 26.0p) to raise a total of £1,800,000, before expenses (the "Subscription"). It is expected that the funds raised under the Subscription will be utilised for general working capital purposes.

 

Under the Subscription, the Investors will also receive warrants to subscribe for further Ordinary Shares at a price of 29 pence per Ordinary Share at any date up to and including 31 December 2025 (the "Warrants").  The Investors will receive 1 Warrant for every 3 new Ordinary Shares subscribed.  A total of 2,608.696 Warrants will be issued.

 

Among the investors under the Subscription are two existing substantial shareholders of the Company, Constantine Logothetis and Nistadgruppen AS ("Nistad").  Mr Logothetis has subscribed for 2,608,696 new Ordinary Shares and Nistad for 1,304,348 new Ordinary Shares. As Mr Logothetis and Nistad each have an existing interest in more than 10% of the Company's Ordinary Shares, their subscriptions constitute related party transactions under the AQSE Growth Market Apex Rules.  The Board has concluded, having exercised reasonable care, skill and diligence, that their Subscriptions are fair and reasonable as far as the shareholders of the Company are concerned.

 

The new Ordinary Shares will be allotted under the Company's existing unspent share issue authorities and are expected to be admitted to trading on the AQSE Growth Market on 29 December 2023 ("Admission"). 

 

Radu Florescu, Chairman of SulNOx, commented, "We are delighted to receive significant further support from our two largest shareholders, Mr Logothetis and Nistadgruppen AS, after both made earlier investments in recent months. This investor group includes new individual and institutional investors that bring additional welcome diversity to our capital base and strengthens the company's firepower. Most importantly, this new commitment of funds is testament to the encouraging progress SulNOx is making in expanding the global footprint of its key products to generate revenue, including from blue chip customers. It is a very significant vote of confidence in our strategy and materially aides SulNOx in achieving its goals.  Funds will be used to establish product stock points in strategic locations worldwide to meet rising product demand, hire additional key personnel, further R&D for biofuels and general working capital.  We look forward to reporting further progress in due course."

 

Holdings in the Company

 

Following Admission, the percentage of Ordinary Shares held by significant shareholders will be, to the best of the knowledge of the Company, as follows:



 

 

Shareholder

Current Ordinary Shares Held

% of Current Ordinary Shares Held

Ordinary Shares Held on Admission

% of Ordinary Shares Held on Admission

 





Constantine Logothetis *

25,848,799

22.83%

28,457,495

23.51%

Nistadgruppen AS

16,306,763

14.40%

17,611,111

14.55%

Stephen Bamford

8,728,043

7.71%

8,728,043

7.21%

James Redman Jr.

8,659,200

7.65%

8,659,200

7.15%

Richard Leggatt

6,807,500

6.01%

6,807,500

5.62%

Unicorn Asset Management

6,536,565

5.77%

6,536,565

5.40%

Angela Bravo **

5,719,010

5.05%

5,719,010

4.72%

 

* This includes shares held by Tergeo Ltd, a company in which Constantine Logothetis holds a majority interest.

 

** This includes shares owned by Sungold Escrow Nominees Ltd, a company controlled by Ms Bravo, and by trusts for the benefit of Ms Bravo's immediate family.  Ms Bravo's previously reported holding included voting rights for but not beneficial ownership of 2,298,810 Ordinary Shares.  The current holding includes 3,420,200 with both voting rights and beneficial ownership of Ordinary Shares and 2,298,810 with just voting rights.

 

Total Voting Rights

 

On Admission, the Company will have 121,050,474 Ordinary Shares in issue, each with one voting right. The Company does not hold any shares in treasury and therefore the total number of voting rights in the Company is 121,050,474. This figure should be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

 

- Ends -

 

For further information please contact:

 

SulNOx Group plc
Steven Cowin, CFO

 

Tel: 07624 491 821



Allenby Capital Limited

(AQSE Corporate Adviser)

Nick Harriss / John Depasquale

Tel: 020 3328 5656

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXFLFITFRLLFIV]]>

View more ...

SNOX announcementsAll announcements

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal